A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Cdk5 Substrate | Cdk5 Substrate is a biological active peptide. (substrate for the cdc2 protein kinase). Uses: Scientific research. Group: Peptides. CAS No. 164669-07-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P2668. |  |
| CDK6/CyclinD1, active, His/GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| CDK7/Cyclin H1/MNAT1, active, His tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| CDK7-IN-2 | CDK7-IN-2 is a potent inhibitor of CDK7. CDK7 is implicated in both temporal control of the cell cycle and transcriptional activity. CDK7 is implicated in the transcriptional initiation process by phosphorylation of Rbpl subunit of RNA Polymerase II (RNAPII). CDK7 has the potential for the research of cancer disease, in particular aggressive and hard- to-treat cancers (extracted from patent WO2019099298A1, compound 1) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2326428-19-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-143587. | |
| CDK8-IN-13 | CDK8-IN-13 is a potent, selective and orally active CDK8 inhibitor with an IC 50 value of 51.9 nM. CDK8-IN-13 induces Apoptosis. CDK8-IN-13 decreases the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 shows antitumor activity [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 918523-75-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-149974. | |
| CDK9/CyclinK, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| CDK9-IN-1 | Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not available. We present a selective inhibitor family of CDK9 based on the 4-phenylamino-6- phenylpyrimidine nucleus. We show a convenient synthetic method to prepare a useful intermediate and its derivatisation resulting in novel compounds. The CDK9 inhibitory activity of the derivatives was measured in specific kinase assay and the CDK inhibitory profile of the best ones (IC50 > 100nM) was determined. The most selective compounds had high selectivity over CDK1, 2, 3, 5, 6, 7 and showed at least one order of magnitude higher inhibitory activity over CDK4 inhibition. The most selective molecules were examined in cytotoxicity assays and their ability to inhibit HIV-1 replication was determined in cellular assays. Synonyms: CDK9-IN-1; CDK9 IN 1. Grades: >98%. CAS No. 1415559-43-1. Molecular formula: C26H21N5O4S. Mole weight: 499.54. |  |
| CDK9-IN-14 | CDK9-IN-14 is a potent and selective CDK9 inhibitor with IC 50 of 6.92 nM. CDK9-IN-14 has a relatively strong inhibitory effect on MV4;11 cells and in vivo tumor models, and has a good selectivity and a low toxicity and few side effects [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2650640-17-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-143585. | |
| CDK9-IN-2 | CDK9-IN-2 is a novel cyclin-dependent kinase 9(CDK9) inhibitor. Synonyms: CDK9 Inhibitor II; CDK9 Inhibitor 2; CDK9-In-2; CDK9-IN2. Grades: >98%. CAS No. 1263369-28-3. Molecular formula: C23H25ClFN5. Mole weight: 425.93. | |
| CDK9-IN-30 | CDK9-IN-30 is a CDK9 inhibitor that inhibits HIV-1 viral replication [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 748146-89-6. Pack Sizes: 5 mg; 10 mg. Product ID: HY-147131. | |
| CDK9-IN-34 | CDK9-IN-34 (Compound 1b) is an inhibitor for CDK9 with an IC 50 of 0.25 μM. CDK9-IN-34 exhibits cytotoxicity to cancer cell HCT116, MCF7 and K652 with IC 50 of 1.43, 3.01 and 50.27 μM, respectively. CDK9-IN-34 exhibits antiviral activity against coronavirus 229E with an IC 50 of 145.92 μM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 252725-86-3. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-164619. | |
| CDK9-IN-6 | CDK9-IN-6, one of the CDK9 inhibitors, probably have potential activity in influencing cell cycle of T-type cells. Uses: Cdk9-in-6 is one of the cdk9 inhibitors that probably have potential activity in influencing cell cycle of t-type cells. Synonyms: CDK9-IN-6; SCHEMBL12466375; SCHEMBL15378321; SCHEMBL15378323; CS-4615; CS 4615; CS4615. Grades: 98%. CAS No. 1391855-95-0. Molecular formula: C27H37ClN6O2. Mole weight: 513.08. | |
| Cdk9 Inhibitor II | Cdk9 Inhibitor II. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Cdk9 Inhibitor II, CHEMBL1823556, 4-(3,5-Diamino-1H-pyrazol-4-ylazo)-phenol, 4-[(E)-(3,5-Diamino-1h-Pyrazol-4-Yl)diazenyl]phenol, 140651-18-9, F18, 2clx, 3tn8, SureCN3310182, SureCN12589685, UNII-ZG0O47K626, CAN508, CHEMBL215205, CTK8F0280, CAN-508, MolPort-009-019-369, HMS3229D19, DNC006929, IN1367, NSC741614. Product Category: Heterocyclic Organic Compound. Appearance: crystalline solid. CAS No. 140651-18-9. Molecular formula: C9H10N6O. Mole weight: 218.2. Purity: ≥95%. IUPACName: 4-[(3,5-diamino-1H-pyrazol-4-yl)hydrazinylidene]cyclohexa-2,5-dien-1-one. Canonical SMILES: C1=CC(=O)C=CC1=NNC2=C(NN=C2N)N. Product ID: ACM140651189. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Cdk9 Inhibitor II - CAS 140651-18-9 | The Cdk9 Inhibitor II, also referenced under CAS 140651-18-9, controls the biological activity of Cdk9. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| Cdk/CKI Inhibitor, (R)-DRF053 - CAS 1186647-87-9 | The Cdk/CKI Inhibitor, (R)-DRF053, also referenced under CAS 1186647-87-9, controls the biological activity of Cdk/CKI. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| CDK/CRK Inhibitor | CDK/CRK inhibitor is an inhibitor of cyclin-dependent kinases (CDK) and CDK-related kinases (CRK) with IC50 values ranging from 9-839 nM. It is also a potent, selective & ATP-competitive inhibitor of CDKs. CDK/CRK inhibitor exhibits less than 20% inhibition of 60 non-CDK/CRK kinases at 1 μM. Synonyms: Cdk7 Inhibitor IV; Cyclin-dependent kinase 7 Inhibitor IV; Cyclin-dependent kinase/CDK-related kinase Inhibitor; RGB-286147; RGB 286147. Grades: ≥98%. CAS No. 784211-09-2. Molecular formula: C23H22Cl2N4O3. Mole weight: 473.4. | |
| Cdk/Crk Inhibitor - CAS 784211-09-2 | The Cdk/Crk Inhibitor, also referenced under CAS 784211-09-2, controls the biological activity of Cdk/Crk. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| CDKI-73 | CDKI-73 was cytotoxic to all of the CLL samples tested (n = 38) with a mean LD50 value of 0.08μM ± 0.10 μM following exposure to drug for 48h. In contrast, normal B-lymphocytes (n = 10) and CD34+ normal bone marrow cells (n = 5) were significantly less susceptible to the cytotoxic effects of CDKI-73. Treatment of CLL cells with 0.1 μM CDKI-73 for 4h inhibited the phosphorylation of cdk9 and ser2 of RNA polymerase II. CDKI-73 induces a rapid loss of MCL1 protein and this is mediated by significant inhibition at the level of gene transcription. However, this inhibition is not restricted to MCL1 as similar reductions in XIAP and CCND2 were also observed following exposure to CDKI-73 for 4h. CDKI-73 rapidly inhibited cellular CDK9 kinase activity and down-regulated the RNAPII phosphorylation. CDK9 shRNA was also found to down-regulate the Mnk1 expression. Both CDKI-73 and CDK9 shRNA decreased anti-apoptotic proteins Mcl-1 and Bcl-2 and induced apoptosis. CDKI-73 exhibited a favorable pharmacokinetic profile with oral bioavailability of F=56% following a single intravenous bolus dose at 2 mg/kg and an oral dose at 10 mg/kg in mice. Synonyms: CDKI-73; CDKI 73; CDKI73. Grades: >98%. CAS No. 1421693-22-2. Molecular formula: C15H15FN6O2S2. Mole weight: 394.45. | |
| CDKI-83 | CDKI-83 is a potent CDK9 inhibitor. The compound shows effective anti-proliferative activity in human tumour cell lines with GI50 <1 μM, and is capable of inducing apoptosis in A2780 human ovarian cancer cells as determined by the activated caspase-3, Annexin V/PI double staining and accumulated cells at the sub-G1 phase of cellcycle. The research results suggest that combined inhibition of CDK9 and CDK1 may result in the effective induction of apoptosis and CDKI-83 has the potential to be developed as an anti-cancer agent. Synonyms: CDKI83; CDKI 83. CAS No. 1189558-88-0. Molecular formula: C21H23N7O3S2. Mole weight: 485.58. | |
| CDK-IN-2 | CDK-IN-2 is a potent and sepecific CDK inhibitor. Synonyms: CDK inhibitor II. Grades: >98%. CAS No. 1269815-17-9. Molecular formula: C18H19ClFN3O2. Mole weight: 363.81. | |
| CDKN3, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| CDMT | It is a stable, crystalline compound, with good solubility in organic solvents, and is commercially available in large quantities. Uses: Peptide Synthesis. Group: Coupling Reagents. Alternative Names: 2-Chloro-4,6-dimethoxy-1,3,5-triazine. CAS No. 3140-73-6. |  Luxembourg Bio Technologies |
| CDN1163 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| CDN 1163 | CDN 1163 is an allosteric activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2), increasing Ca2+-ATPase activity and Ca2+ uptake by ER microsomes from obese mice. It reduces fasting glucose levels and adipose tissue weight, and increases energy expenditure in ob/ob mice. CDN 1163 has the potential to treat type-2 diabetes and metabolic dysfunction. Synonyms: CDN-1163; CDN 1163; CDN1163; 4-(1-Methylethoxy)-N-(2-methyl-8-quinolinyl)benzamide; 4-Isopropoxy-N-(2-methylquinolin-8-yl)benzamide. Grades: ≥98% by HPLC. CAS No. 892711-75-0. Molecular formula: C20H20N2O2. Mole weight: 320.38. | |
| cDNA Library | cDNA Library Construction Service can Include: Group: Molecular Biology. US Biological Life Sciences. |  Worldwide |
| cDNA Library, Vector Preparation | cDNA Library Construction Service Includes: Group: Molecular Biology. US Biological Life Sciences. | Worldwide |
| CDNF human | recombinant, expressed in E. coli, ?98% (SDS-PAGE), ?98% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol synthase | This enzyme catalyses one of the steps in the biosynthesis of polar lipids in archaea, which are characterized by having an sn-glycerol 1-phosphate backbone rather than an sn-glycerol 3-phosphate backbone as is found in bacteria and eukaryotes. The enzyme requires Mg2+ and K+ for maximal activity. Group: Enzymes. Synonyms: carS (gene name); CDP-2,3-di-O-geranylgeranyl-sn-glycerol synthase; CTP:2,3-GG-GP ether cytidylyltransferase; CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase; CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol synthase; CTP:2,3-bis-O-(geranylgeranyl)-sn-glycero-1-phosphate cytidylyltransferase; CDP-unsaturated archaeol synthase; . Enzyme Commission Number: EC 2.7.7.67. CAS No. 329791-09-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3278; CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol synthase; EC 2.7.7.67; 329791-09-5; carS (gene name); CDP-2,3-di-O-geranylgeranyl-sn-glycerol synthase; CTP:2,3-GG-GP ether cytidylyltransferase; CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase; CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol synthase; CTP:2,3-bis-O-(geranylgeranyl)-sn-glycero-1-phosphate cytidylyltransferase; CDP-unsaturated archaeol synthase; CDP-archaeol synthase (incorrect). Cat No: EXWM-3278. |  |
| CDP-4-dehydro-6-deoxyglucose reductase | The enzyme consists of two proteins. One forms an enzyme-bound adduct of the CDP-4-dehydro-6-deoxyglucose with pyridoxamine phosphate, in which the 3-hydroxy group has been removed. The second catalyses the reduction of this adduct by NAD(P)H and release of the CDP-4-dehydro-3,6-dideoxy-D-glucose and pyridoxamine phosphate. Group: Enzymes. Synonyms: CDP-4-keto-6-deoxyglucose reductase; cytidine diphospho-4-keto-6-deoxy-D-glucose reductase; cytidine diphosphate 4-keto-6-deoxy-D-glucose-3-dehydrogenase; CDP-4-keto-deoxy-glucose reductase; CDP-4-keto-6-deoxy-D-glucose-3-dehydrogenase system; NAD(P)H:CDP-4-keto-6-deoxy-D-glucose oxidoreductase. Enzyme Commission Number: EC 1.17.1.1. CAS No. 37256-87-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1080; CDP-4-dehydro-6-deoxyglucose reductase; EC 1.17.1.1; 37256-87-4; CDP-4-keto-6-deoxyglucose reductase; cytidine diphospho-4-keto-6-deoxy-D-glucose reductase; cytidine diphosphate 4-keto-6-deoxy-D-glucose-3-dehydrogenase; CDP-4-keto-deoxy-glucose reductase; CDP-4-keto-6-deoxy-D-glucose-3-dehydrogenase system; NAD(P)H:CDP-4-keto-6-deoxy-D-glucose oxidoreductase. Cat No: EXWM-1080. | |
| CDP 840 hydrochloride | CDP 840 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 162542-90-7. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| CDP 840 hydrochloride | CDP 840 hydrochloride is a potent and selective inhibitor of phosphodiesterase 4 (PDE4) (IC50 = 12 nM). It competitively inhibits all PDE4 isoenzymes. Synonyms: CDP840; CDP-840; CDP 840; CDP840 HCl; CDP840HCl. 4-[(2R)-2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-phenylethyl]-pyridine hydrochloride. Grades: ≥98% by HPLC. CAS No. 162542-90-7. Molecular formula: C25H27NO2.HCl. Mole weight: 409.95. | |
| CDP-abequose synthase | Isolated from Yersinia pseudotuberculosis and Salmonella enterica. Group: Enzymes. Synonyms: rfbJ (gene name). Enzyme Commission Number: EC 1.1.1.341. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0256; CDP-abequose synthase; EC 1.1.1.341; rfbJ (gene name). Cat No: EXWM-0256. | |
| CDP-β-S | CDP-β-S is a CDP binding proteins regulator with a higher stability. It is used for characterization of CDP-responsive receptors, determination of their stereospecificity and labelling with thio-reactive reporter groups. Synonyms: Cytidine- 5'- O- (2- thiodiphosphate), sodium salt. Grades: ≥ 95% by HPLC. CAS No. 497064-72-9. Molecular formula: C9H15N3O10P2S (free acid). Mole weight: 419.2 (free acid). | |
| cDPCP | ?98% (HPLC), solid. Group: Fluorescence/luminescence spectroscopy. | |
| CDP-diacylglycerol diphosphatase | This enzyme belongs to the family of hydrolases, specifically those acting on acid anhydrides in phosphorus-containing anhydrides. The systematic name of this enzyme class is CDP-diacylglycerol phosphatidylhydrolase. Other names in common use include cytidine diphosphodiacylglycerol pyrophosphatase, and CDP diacylglycerol hydrolase. This enzyme participates in glycerophospholipid metabolism. Group: Enzymes. Synonyms: cytidine diphosphodiacylglycerol pyrophosphatase; CDP diacylglycerol hydrolase. Enzyme Commission Number: EC 3.6.1.26. CAS No. 62213-20-1. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4610; CDP-diacylglycerol diphosphatase; EC 3.6.1.26; 62213-20-1; cytidine diphosphodiacylglycerol pyrophosphatase; CDP diacylglycerol hydrolase. Cat No: EXWM-4610. | |
| CDP-diacylglycerol-glycerol-3-phosphate 1-phosphatidyltransferase | The enzyme catalyses the committed step in the biosynthesis of acidic phospholipids known by the common names phophatidylglycerols and cardiolipins. Group: Enzymes. Synonyms: glycerophosphate phosphatidyltransferase; 3-phosphatidyl-1'-glycerol-3'-phosphate synthase; CDP. Enzyme Commission Number: EC 2.7.8.5. CAS No. 9068-49-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3343; CDP-diacylglycerol-glycerol-3-phosphate 1-phosphatidyltransferase; EC 2.7.8.5; 9068-49-9; glycerophosphate phosphatidyltransferase; 3-phosphatidyl-1'-glycerol-3'-phosphate synthase; CDPdiacylglycerol:glycerol-3-phosphate phosphatidyltransferase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol (CDP-diglyceride):sn-glycerol-3-phosphate phosphatidyltransferase; phosphatidylglycerophosphate synthase; phosphatidylglycerolphosphate synthase; PGP synthase; CDP-diacylglycerol-sn-glycerol-3-phosphate 3-phosphatidyltransferase; CDP-diacylglycerol:sn-glycero-3-phosphate phosphatidyltransferase; glycerol phosphate phosphatidyltransferase; glycerol 3-phosphate phosphatidyltransferase; phosphatidylglycerol phosphate synthase; phosphatidylglycerol phosphate synthetase; phosphatidylglycerophosphate synthetase; sn-glycerol-3-phosphate phosphatidyltransferase. Cat No: EXWM-3 | |
| CDP-diacylglycerol-inositol 3-phosphatidyltransferase | This enzyme belongs to the family of transferases, specifically those transferring non-standard substituted phosphate groups. This enzyme participates in glycerophospholipid metabolism and phosphatidylinositol signaling system. Group: Enzymes. Synonyms: CDP-diglyceride-inositol phosphatidyltransferase; phosphatidylinositol synthase; CDP-diacylglycerol-inositol phosphatidyltransferase; CDP-diglyceride:inositol transferase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol:myo-inositol 3-phosph. Enzyme Commission Number: EC 2.7.8.11. CAS No. 9027-1-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3311; CDP-diacylglycerol-inositol 3-phosphatidyltransferase; EC 2.7.8.11; 9027-01-4; CDP-diglyceride-inositol phosphatidyltransferase; phosphatidylinositol synthase; CDP-diacylglycerol-inositol phosphatidyltransferase; CDP-diglyceride:inositol transferase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol:myo-inositol 3-phosphatidyltransferase; CDP-DG:inositol transferase; cytidine diphosphodiglyceride-inositol phosphatidyltransferase; CDP-diacylglycerol:myo-inositol-3-phosphatidyltransferase; CDP-diglyceride-inositol transferase; cytidine diphosphoglyceride-inositol phosphatidyltransferase; cytidine diphosphoglyceride-inositol transferase. Cat No: EXWM-3311. | |
| CDP-diacylglycerol-serine O-phosphatidyltransferase | This enzyme belongs to the family of transferases, specifically those transferring non-standard substituted phosphate groups. This enzyme participates in glycine, serine and threonine metabolism and glycerophospholipid metabolism. Group: Enzymes. Synonyms: phosphatidylserine synthase; CDPdiglyceride-serine O-phosphatidyltransferase; PS synthase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol (CDPdiglyceride):L-serine O-phosphatidyltransferase; phosphatidylserine synthetase; CDP-di. Enzyme Commission Number: EC 2.7.8.8. CAS No. 9068-48-8. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3346; CDP-diacylglycerol-serine O-phosphatidyltransferase; EC 2.7.8.8; 9068-48-8; phosphatidylserine synthase; CDPdiglyceride-serine O-phosphatidyltransferase; PS synthase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol (CDPdiglyceride):L-serine O-phosphatidyltransferase; phosphatidylserine synthetase; CDP-diacylglycerol-L-serine O-phosphatidyltransferase; cytidine diphosphoglyceride-serine O-phosphatidyltransferase; CDP-diglyceride-L-serine phosphatidyltransferase; CDP-diglyceride:serine phosphatidyltransferase; cytidine 5'-diphospho-1,2-diacyl-sn-glycerol:L-serine O-phosphatidyltransferase; CDP-diacylglycerol:L-serine 3-O-phosphatidyltransferase. Cat No: EXWM-3346. | |
| CDP-ethanolamine | CDP-ethanolamine, a pivotal intermediary in the biosynthesis of membrane phospholipids, assumes an indispensable function in preserving cellular membrane integrity. Clinical research evince that it ameliorates cognitive development in patients diagnosed with neurodegenerative conditions, notably Alzheimer's disease. Furthermore, it potentially mitigates glaucoma symptoms by diminishing intraocular pressure while enhancing blood flow, thereby ameliorating optic nerve functionality. Synonyms: Cytidine-5'-diphosphate ethanolamine; Cytidine-5'-diphosphateethanolamine. Grades: ≥ 95% by HPLC. CAS No. 3036-18-8. Molecular formula: C11H20N4O11P2. Mole weight: 446.25. | |
| CDP-Gel / CDP-Agarose | CDP-Gel is the CDP coupled to a polymeric gel by the terminal phosphate, which can be used in the affinity purification of sialyltransferases. Synonyms: Cytidine- 5'- O- diphosphate, immobilized on a polymeric matrix. | |
| CDP-glucose 4,6-dehydratase | Requires bound NAD+. Group: Enzymes. Synonyms: cytidine diphosphoglucose oxidoreductase; CDP-glucose 4,6-hydro-lyase. Enzyme Commission Number: EC 4.2.1.45. CAS No. 37259-55-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5034; CDP-glucose 4,6-dehydratase; EC 4.2.1.45; 37259-55-5; cytidine diphosphoglucose oxidoreductase; CDP-glucose 4,6-hydro-lyase. Cat No: EXWM-5034. | |
| CDP-glycerol diphosphatase | This enzyme belongs to the family of hydrolases, specifically those acting on acid anhydrides in phosphorus-containing anhydrides. The systematic name of this enzyme class is CDP-glycerol phosphoglycerohydrolase. Other names in common use include CDP-glycerol pyrophosphatase, and cytidine diphosphoglycerol pyrophosphatase. This enzyme participates in glycerophospholipid metabolism. Group: Enzymes. Synonyms: CDP-glycerol pyrophosphatase; cytidine diphosphoglycerol pyrophosphatase. Enzyme Commission Number: EC 3.6.1.16. CAS No. 37289-28-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4600; CDP-glycerol diphosphatase; EC 3.6.1.16; 37289-28-4; CDP-glycerol pyrophosphatase; cytidine diphosphoglycerol pyrophosphatase. Cat No: EXWM-4600. | |
| CDP-glycerol glycerophosphotransferase | This enzyme belongs to the family of transferases, specifically those transferring non-standard substituted phosphate groups. Group: Enzymes. Synonyms: teichoic-acid synthase; cytidine diphosphoglycerol glycerophosphotransferase; poly(glycerol phosphate) polymerase; teichoic acid glycerol transferase; glycerophosphate synthetase; CGPTase. Enzyme Commission Number: EC 2.7.8.12. CAS No. 9076-71-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3312; CDP-glycerol glycerophosphotransferase; EC 2.7.8.12; 9076-71-5; teichoic-acid synthase; cytidine diphosphoglycerol glycerophosphotransferase; poly(glycerol phosphate) polymerase; teichoic acid glycerol transferase; glycerophosphate synthetase; CGPTase. Cat No: EXWM-3312. | |
| CDPI3 MGB CPG | CDPI3 MGB CPG is an exquisitely tailored and purposeful compound that garners marked proficiency within the realm of biomedicine, and has demonstrated efficacy in addressing diverse manifestations of cancer. Its unique mechanism of action bespeaks its ability to regulate crucial enzymes involved in tumor expansion, exclaiming its aptitude for both solid tumors and leukemia. Moreover, corresponding research has unveiled the possibility of applying this compound as an efficacious treatment modality for autoimmune disorders. Synonyms: 5-(6-(6-(6-(6-Dimethoxytrityloxyhexanoyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbonyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbonyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carboxamido)pentyl-1-O-diglycoloyl long chain alkylamino CPG. Mole weight: 831.87. | |
| CDP-L-myo-inositol myo-inositolphosphotransferase | In many organisms this activity is catalysed by a bifunctional enzyme. The di-myo-inositol-1,3'-phosphate-1'-phosphate synthase domain of the bifunctional EC 2.7.7.74/EC 2.7.8.34 (CTP:inositol-1-phosphate cytidylyltransferase/CDP-inositol:inositol-1-phosphate transferase) uses only 1L-myo-inositol 1-phosphate as an alcohol acceptor, but CDP-glycerol, as well as CDP-1L-myo-inositol and CDP-D-myo-inositol, are recognized as alcohol donors. The enzyme is involved in biosynthesis of bis(1L-myo-inositol) 1,3-phosphate, a widespread organic solute in microorganisms adapted to hot environments. Group: Enzymes. Synonyms: CDP-inositol:inositol-1-phosphate transferase (bifunctional CTP:inositol-1-phosphate cytidylyltransferase/CDP-inositol:inositol-1-phosphate transferase (IPCT/DIPPS)); DIPPS . Enzyme Commission Number: EC 2.7.8.34. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3333; CDP-L-myo-inositol myo-inositolphosphotransferase; EC 2.7.8.34; CDP-inositol:inositol-1-phosphate transferase (bifunctional CTP:inositol-1-phosphate cytidylyltransferase/CDP-inositol:inositol-1-phosphate transferase (IPCT/DIPPS)); DIPPS (bifunctional CTP:inositol-1-phosphate cytidylyltransferase/CDP-inositol:inositol-1-phosphate transferase (IPCT/DIPPS)). Cat No: EXWM-3333. | |
| CDP - lyophilized | CDP - lyophilized is a biomedical compound used in the research of neurological disorders. Substances like Cytidine-5'-diphosphate (CDP) function as a precursor to nucleotides, contributing to RNA and DNA enhancement. This lyophilized form offering improved stability and ensures optimal compound delivery. Synonyms: Cytidine-5'-diphosphate, Sodium salt. Grades: ≥ 96% by HPLC. Molecular formula: C9H15N3O11P2 (free acid). Mole weight: 403.17 (free acid). | |
| CDP-paratose 2-epimerase | Requires NAD+. Group: Enzymes. Synonyms: CDP-paratose epimerase; cytidine diphosphoabequose epimerase; cytidine diphosphodideoxyglucose epimerase; cytidine diphosphoparatose epimerase; cytidine diphosphate paratose-2-epimerase; CDP-abequose epimerase (incorrect); CDP-D-abequose 2-epimerase (incorrect); CDP-tyvelose 2-epimerase. Enzyme Commission Number: EC 5.1.3.10. CAS No. 37318-36-8. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5395; CDP-paratose 2-epimerase; EC 5.1.3.10; 37318-36-8; CDP-paratose epimerase; cytidine diphosphoabequose epimerase; cytidine diphosphodideoxyglucose epimerase; cytidine diphosphoparatose epimerase; cytidine diphosphate paratose-2-epimerase; CDP-abequose epimerase (incorrect); CDP-D-abequose 2-epimerase (incorrect); CDP-tyvelose 2-epimerase. Cat No: EXWM-5395. | |
| CDP-paratose synthase | The enzyme is involved in synthesis of paratose and tyvelose, unusual 3,6-dideoxyhexose sugars that form part of the O-antigen in the lipopolysaccharides of several enteric bacteria. Isolated from Salmonella enterica subsp. enterica serovar Typhi (Salmonella typhi). Group: Enzymes. Synonyms: rfbS (gene name). Enzyme Commission Number: EC 1.1.1.342. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0257; CDP-paratose synthase; EC 1.1.1.342; rfbS (gene name). Cat No: EXWM-0257. | |
| CDPPB | CDPPB. Group: Biochemicals. Alternative Names: 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide. Grades: Highly Purified. CAS No. 781652-57-1. Pack Sizes: 5mg. Molecular Formula: C23H16N4O, Molecular Weight: 364.4. US Biological Life Sciences. | Worldwide |
| CDPPB | CDPPB is a selective, orally active mGluR5 allosteric modulator. CDPPB increases AKT and ERK1/2 activation and augments the BDNF mRNA. CDPPB inhibits caspase-3 activation and mitochondrial dysfunction. CDPPB improves cognitive impairment, depression, and Huntington's disease [1] [2] [3] [4] [5] [6] [7] [8] [9]. Uses: Scientific research. Group: Signaling pathways. CAS No. 781652-57-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14569. | |
| CDPPB | CDPPB is a positive allosteric modulator of mGlu5 receptor (EC50 = 10 and 20 nM for human and rat receptors, respectively). Study shows that CDPPB has a therapeutic effect for cognitive deficits in schizophrenia and pathology in Huntington's disease. CDPPB is a potential antipsychotic and nootropic drug. Synonyms: 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide; 3-cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide. Grades: ≥98% by HPLC. CAS No. 781652-57-1. Molecular formula: C23H16N4O. Mole weight: 364.4. | |
| CDPPB | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopypharmaceutical toxicology. | |
| CDP-ribitol ribitolphosphotransferase | This enzyme belongs to the family of transferases, specifically those transferring non-standard substituted phosphate groups. Group: Enzymes. Synonyms: teichoic-acid synthase; polyribitol phosphate synthetase; teichoate synthetase; poly(ribitol phosphate) synthetase; polyribitol phosphate polymerase; teichoate synthase. Enzyme Commission Number: EC 2.7.8.14. CAS No. 9076-71-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3314; CDP-ribitol ribitolphosphotransferase; EC 2.7.8.14; 9076-71-5; teichoic-acid synthase; polyribitol phosphate synthetase; teichoate synthetase; poly(ribitol phosphate) synthetase; polyribitol phosphate polymerase; teichoate synthase. Cat No: EXWM-3314. | |
| CdS CdSe Core Shell Nanoparticles | CdS CdSe Core Shell Nanoparticles. Group: Core shell nanoparticles. 99.9%. |  |
| CdSe CdS Core Shell Nanoparticles | CdSe CdS Core Shell Nanoparticles. Group: Core shell nanoparticles. 99.9%. | |
| CdSe/CdS core-shell type quantum rods | CdSe/CdS core-shell type quantum rods. Group: Quantum dots. | |
| CdSe/CdS core-shell type quantum rods fluorescence λem 530 nm, 5 mg/mL in hexane | CdSe/CdS core-shell type quantum rods fluorescence λem 530 nm, 5 mg/mL in hexane. Group: Core type quantum dots. | |
| CdSe/CdS core-shell type quantum rods fluorescence λem 560 nm, 5 mg/mL in hexane | CdSe/CdS core-shell type quantum rods fluorescence λem 560 nm, 5 mg/mL in hexane. Group: Core type quantum dots. | |
| CdSe/CdS core-shell type quantum rods fluorescence λem 590 nm, 5 mg/mL in hexane | CdSe/CdS core-shell type quantum rods fluorescence λem 590 nm, 5 mg/mL in hexane. Group: Core type quantum dots. | |
| CdSe/CdS core-shell type quantum rods fluorescence λem 620 nm, 5 mg/mL in hexane | CdSe/CdS core-shell type quantum rods fluorescence λem 620 nm, 5 mg/mL in hexane. Group: Core type quantum dots. | |
| CdSe HgSe Core Shell Nanoparticles | CdSe HgSe Core Shell Nanoparticles. Group: Core shell nanoparticles. 99.9%. | |
| CdSe Quantum Dots | CdSe Quantum Dots. Group: Quantum dots. | |
| CdSe SiO2 Core Shell Nanoparticles | CdSe SiO2 Core Shell Nanoparticles. Group: Core shell nanoparticles. 99.9%. | |
| CdSeS/ZnS alloyed quantum dots | CdSeS/ZnS alloyed quantum dots. Uses: Cdse/cds quantum rods possess excellent optoelectronic properties such as tunable emission wavelength, high extinction coefficient, polarized emission, enhanced quantum yield and exhibit an order of magnitude higher brightness. these outstanding properties make the cdse/cds nanorods suitable for applications such as displays, solid state lighting (led) and lasers as these require strong fluorescence. Group: Quantum dots. | |
| CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence λ | CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence &lambda. Group: Alloyed quantum dots. | |
| CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence λem 490 nm, 6 nm diameter | CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence λem 490 nm, 6 nm diameter. Group: Alloyed quantum dots. | |
| CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence λem 540 nm, 6 nm diameter | CdSeS/ZnS alloyed quantum dots COOH functionalized, fluorescence λem 540 nm, 6 nm diameter. Group: Alloyed quantum dots. | |
| CdSeS/ZnS alloyed quantum dots fluorescence λ | CdSeS/ZnS alloyed quantum dots fluorescence &lambda. Group: Alloyed quantum dots. | |
| CdSeS/ZnS alloyed quantum dots fluorescence λem 450 nm, 6 nm diameter, 1 mg/mL in toluene | CdSeS/ZnS alloyed quantum dots fluorescence λem 450 nm, 6 nm diameter, 1 mg/mL in toluene. Group: Core type quantum dots. | |
| CdSeS/ZnS alloyed quantum dots fluorescence λem 490 nm, 6 nm diameter | CdSeS/ZnS alloyed quantum dots fluorescence λem 490 nm, 6 nm diameter. Group: Alloyed quantum dots. | |
Our database is helping our users find suppliers everyday.
